Form 4: Charles River Labs Exec Trades Shares
Statement of Changes in Beneficial Ownership
Mark Mintz, EVP and Chief Information Officer at Charles River Laboratories, reported transactions involving company common stock.
Summary
- Mark Mintz, EVP, Chief Information Officer of Charles River Laboratories, engaged in stock transactions.
- On May 29, 2026, 2,534 shares of common stock were acquired at a price of $180.71 per share.
- Following this acquisition, Mintz beneficially owned 9,915 shares.
- On May 30, 2026, 305 shares were disposed of at $180.71 per share, leaving 9,610 shares.
- On May 31, 2026, an additional 64 shares were disposed of at $180.71 per share, resulting in 9,546 shares.
- The filing also notes that unvested restricted stock units will vest annually on May 29, 2027, May 29, 2028, May 29, 2029, and May 29, 2030.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this filing as neutral, reflecting routine executive stock transactions without strong positive or negative indicators.
Positives
- Acquisition of 2,534 shares by a key executive on May 29, 2026, at $180.71 per share, potentially indicating confidence in the company's value.
- The executive still holds a significant number of shares (9,546) after the reported transactions.
Negatives
- Disposal of 305 shares on May 30, 2026, and 64 shares on May 31, 2026, by a key executive, which could be interpreted as a reduction in direct ownership.
Future Outlook
Unvested restricted stock units are scheduled to vest annually through May 29, 2030, indicating a long-term incentive structure for the executive.
Industry Context
StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. The acquisition and subsequent small disposals by an executive at Charles River Laboratories are typical events that investors monitor for insights into management's perception of company value.
Stakeholder Impact
- Shareholders: The transactions may provide minor insights into executive confidence, but the overall impact on share price is likely minimal given the nature of the trades.
Next Steps
- Continued annual vesting of restricted stock units through May 29, 2030.
Key Dates
| Date | Description |
|---|---|
| 05/29/2026 | Earliest transaction date reported; acquisition of 2,534 common shares. |
| 05/29/2027 | First vesting date for a portion of unvested restricted stock units. |
| 05/29/2028 | Second vesting date for a portion of unvested restricted stock units. |
| 05/29/2029 | Third vesting date for a portion of unvested restricted stock units. |
| 05/29/2030 | Fourth and final vesting date for unvested restricted stock units. |
| 05/30/2026 | Transaction date for disposal of 305 common shares. |
| 05/31/2026 | Transaction date for disposal of 64 common shares. |
| 06/02/2026 | Date of signature for the filing. |
Keywords
Form 4, SEC Filing, Insider Trading, Charles River Laboratories, Mark Mintz, Common Stock, Stock Transaction, Executive Compensation, Restricted Stock Units
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.